Cross-resistance to cytosine arabinoside in human acute myeloid leukemia cells selected for resistance to vincristine

Aim: The goals of the study were to reveal the involvement of P-glycoprotein (P-gp), the product of multidrug resistance 1 gene (MDR1) in cellular resistance to vincristine (VCR) and investigate cross-resistance against cytosine arabinoside (Ara-C) in HL60 and HL60/VCR cell lines. Methods: HL60 cell...

Повний опис

Збережено в:
Бібліографічні деталі
Дата:2006
Автори: Gunduz, U., Baran, Y., Uralsup, A.U.
Формат: Стаття
Мова:English
Опубліковано: Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України 2006
Назва видання:Experimental Oncology
Теми:
Онлайн доступ:http://dspace.nbuv.gov.ua/handle/123456789/137564
Теги: Додати тег
Немає тегів, Будьте першим, хто поставить тег для цього запису!
Назва журналу:Digital Library of Periodicals of National Academy of Sciences of Ukraine
Цитувати:Cross-resistance to cytosine arabinoside in human acute myeloid leukemia cells selected for resistance to vincristine / U. Gunduz, Y. Baran, A.U. Uralsup // Experimental Oncology. — 2006. — Т. 28, № 2. — С. 163-165. — Бібліогр.: 16 назв. — англ.

Репозитарії

Digital Library of Periodicals of National Academy of Sciences of Ukraine
id irk-123456789-137564
record_format dspace
spelling irk-123456789-1375642018-06-18T03:03:57Z Cross-resistance to cytosine arabinoside in human acute myeloid leukemia cells selected for resistance to vincristine Gunduz, U. Baran, Y. Uralsup, A.U. Short communications Aim: The goals of the study were to reveal the involvement of P-glycoprotein (P-gp), the product of multidrug resistance 1 gene (MDR1) in cellular resistance to vincristine (VCR) and investigate cross-resistance against cytosine arabinoside (Ara-C) in HL60 and HL60/VCR cell lines. Methods: HL60 cells (human acute myeloid leukemia cell line) were cultured on medium with 1–50 nM of VCR for 4–6 weeks, and VCR resistant cells (HL60/VCR) were selected. The viability of cells was assessed by MTT assay and the expression of MDR1 gene was detected by RT-PCR. Results: No expression of MDR1 gene was revealed in HL60 cells, but MDR1 started to be expressed after incubation of cells with 2 nM of VCR and its expression level elevates with increase of agent concentration. MTT test has shown that HL-60/VCR cells were 75-fold more resistant to VCR and 42-fold higher resistant to cytosine arabinoside (Ara-C) compared to sensitive HL60 cells. Conclusion: Aquired resistance to VCR and cross-resistance to Ara-C correlates with MDR1 gene expression in vitro. Целью работы было исследование участия Р-гликопротеина (Р-gp), продукта гена-1 множе­ственной лекарственной устойчивости (MDR1) в устойчивости клеток лейкемии человека к винкристину (ВКР) и перекрестной резистентности к цитозинарабинозиду (Аrа-C). Методы: клетки острой миелоидной лейкемии линии HL60 культивировали в среде с 1–50 и ВКР в течение 4–6 нед, после чего были отселектированы ВКР-резистентные клетки (HL60/ВКР). Влияние препаратов на жизнеспособность клеток изучали при помощи МТТ-метода, экспресию гена MDR — методом полимеразной цепной реакции обратной транскрипции. Результаты: в клетках линии HL60 экспрессия гена MDR не была выявлена, но была зарегистрирована после инкубации клеток с 2 нM ВКР, причем ее уровень возрастал по мере повышения концентрации ВКР в среде инкубации. Показано, что устойчивость клеток линии HL-60/ВКР к ВКР и Аrа-C в 75 и в 42 раза выше, соотвественно, чем таковая клеток линии HL60. Выводы: приобретенная устойчивость к ВКР и перекрестная устойчивость к Аrа-C коррелирует с уровнем экспрессии гена MDR . 2006 Article Cross-resistance to cytosine arabinoside in human acute myeloid leukemia cells selected for resistance to vincristine / U. Gunduz, Y. Baran, A.U. Uralsup // Experimental Oncology. — 2006. — Т. 28, № 2. — С. 163-165. — Бібліогр.: 16 назв. — англ. 1812-9269 http://dspace.nbuv.gov.ua/handle/123456789/137564 en Experimental Oncology Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України
institution Digital Library of Periodicals of National Academy of Sciences of Ukraine
collection DSpace DC
language English
topic Short communications
Short communications
spellingShingle Short communications
Short communications
Gunduz, U.
Baran, Y.
Uralsup, A.U.
Cross-resistance to cytosine arabinoside in human acute myeloid leukemia cells selected for resistance to vincristine
Experimental Oncology
description Aim: The goals of the study were to reveal the involvement of P-glycoprotein (P-gp), the product of multidrug resistance 1 gene (MDR1) in cellular resistance to vincristine (VCR) and investigate cross-resistance against cytosine arabinoside (Ara-C) in HL60 and HL60/VCR cell lines. Methods: HL60 cells (human acute myeloid leukemia cell line) were cultured on medium with 1–50 nM of VCR for 4–6 weeks, and VCR resistant cells (HL60/VCR) were selected. The viability of cells was assessed by MTT assay and the expression of MDR1 gene was detected by RT-PCR. Results: No expression of MDR1 gene was revealed in HL60 cells, but MDR1 started to be expressed after incubation of cells with 2 nM of VCR and its expression level elevates with increase of agent concentration. MTT test has shown that HL-60/VCR cells were 75-fold more resistant to VCR and 42-fold higher resistant to cytosine arabinoside (Ara-C) compared to sensitive HL60 cells. Conclusion: Aquired resistance to VCR and cross-resistance to Ara-C correlates with MDR1 gene expression in vitro.
format Article
author Gunduz, U.
Baran, Y.
Uralsup, A.U.
author_facet Gunduz, U.
Baran, Y.
Uralsup, A.U.
author_sort Gunduz, U.
title Cross-resistance to cytosine arabinoside in human acute myeloid leukemia cells selected for resistance to vincristine
title_short Cross-resistance to cytosine arabinoside in human acute myeloid leukemia cells selected for resistance to vincristine
title_full Cross-resistance to cytosine arabinoside in human acute myeloid leukemia cells selected for resistance to vincristine
title_fullStr Cross-resistance to cytosine arabinoside in human acute myeloid leukemia cells selected for resistance to vincristine
title_full_unstemmed Cross-resistance to cytosine arabinoside in human acute myeloid leukemia cells selected for resistance to vincristine
title_sort cross-resistance to cytosine arabinoside in human acute myeloid leukemia cells selected for resistance to vincristine
publisher Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України
publishDate 2006
topic_facet Short communications
url http://dspace.nbuv.gov.ua/handle/123456789/137564
citation_txt Cross-resistance to cytosine arabinoside in human acute myeloid leukemia cells selected for resistance to vincristine / U. Gunduz, Y. Baran, A.U. Uralsup // Experimental Oncology. — 2006. — Т. 28, № 2. — С. 163-165. — Бібліогр.: 16 назв. — англ.
series Experimental Oncology
work_keys_str_mv AT gunduzu crossresistancetocytosinearabinosideinhumanacutemyeloidleukemiacellsselectedforresistancetovincristine
AT barany crossresistancetocytosinearabinosideinhumanacutemyeloidleukemiacellsselectedforresistancetovincristine
AT uralsupau crossresistancetocytosinearabinosideinhumanacutemyeloidleukemiacellsselectedforresistancetovincristine
first_indexed 2023-10-18T21:14:20Z
last_indexed 2023-10-18T21:14:20Z
_version_ 1796152290702262272